A small pilot study suggests Epidiolex may have benefits for weight restoration and symptom improvement in anorexia patients.
We examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry.
Curaleaf Laboratories’ sponsorship forms part of its ongoing collaboration with the MCCS.
A new report from the General Pharmaceutical Council’s (GPhC) provides the most detailed regulatory snapshot yet of how medical cannabis is being dispensed across the UK.
How one oncologist is helping redefine patient care and the future of integrated healthcare. Medical cannabis is starting to have a very different kind of conversation...
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval. After seven years of endeavour, and an...
A number of studies have explored whether medicinal cannabis could be used to treat some of the common symptoms.
The international patient-led organisation We, The Patients, will bring its educational series to London next month.
Is regulators’ focus on randomised controlled trials holding back progress in medical cannabis research?
Spain’s Council of Ministers has approved a Royal Decree regulating the medicinal use of cannabis preparations in hospital settings.
The first official evaluation of the CanG reforms highlights early trends in market growth, youth use, health outcomes, and crime.
